SPC
BHVN

Sigma Planning Corp’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Sigma Planning Corp’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,781
Closed -$420K – 1367
2022
Q3 		$420K Buy
2,781
+279
+11% +$41.3K 0.02% 804
2022
Q2 		$365K Sell
2,502
-3,984
-61% -$509K 0.01% 893
2022
Q1 		$769K Buy
6,486
+386
+6% +$48.1K 0.02% 649
2021
Q4 		$841K Sell
6,100
-268
-4% -$34.1K 0.02% 620
2021
Q3 		$885K Sell
6,368
-940
-13% -$117K 0.03% 591
2021
Q2 		$709K Sell
7,308
-1,229
-14% -$99.7K 0.02% 685
2021
Q1 		$584K Buy
8,537
+827
+11% +$66.9K 0.02% 707
2020
Q4 		$661K Sell
7,710
-5,913
-43% -$501K 0.02% 581
2020
Q3 		$886K Sell
13,623
-720
-5% -$47.2K 0.04% 436
2020
Q2 		$1.05M Sell
14,343
-3,513
-20% -$187K 0.05% 380
2020
Q1 		$608K Buy
17,856
+988
+6% +$45.2K 0.04% 434
2019
Q4 		$918K Sell
16,868
-2,100
-11% -$104K 0.04% 426
2019
Q3 		$791K Sell
18,968
-900
-5% -$38K 0.04% 440
2019
Q2 		$870K Buy
19,868
+5,152
+35% +$290K 0.04% 379
2019
Q1 		$757K Sell
14,716
-192
-1% -$8.29K 0.04% 383
2018
Q4 		$551K Buy
14,908
+1,807
+14% +$65.1K 0.04% 411
2018
Q3 		$492K Sell
13,101
-360
-3% -$13.2K 0.03% 492
2018
Q2 		$532K Sell
13,461
-3,680
-21% -$117K 0.04% 437
2018
Q1 		$442K Buy
17,141
+1,338
+8% +$40K 0.03% 469
2017
Q4 		$426K Buy
15,803
+800
+5% +$22K 0.03% 484
2017
Q3 		$561K Buy
+15,003
New +$455K 0.05% 391

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $403M AUM 28.73% 1-Year Est. Return

Sigma Planning Corp's BHVN Position: Q4 2022 in Review

Sigma Planning Corp sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 2,781 shares — an estimated $420K sold.

Sigma Planning Corp first reported a position in BHVN in Q3 2017 and held it in 21 quarters. The position peaked at $1.05M in Q2 2020. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Sigma Planning Corp reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Sigma Planning Corp sold 2,781 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $420K.
  • Sigma Planning Corp first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 21 quarters.
  • Sigma Planning Corp's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $1.05M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Sigma Planning Corp's 13F filing for Q4 2022, filed 24 Jan 2023.